DNTH
Dianthus Therapeutics, Inc.
Stock
$88.21−0.11 (−0.12%)Close Oct 2, 2026
- Operating cash flow, 2025
- −$129M
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | −$129M | — |
| 2024 | −$78M | — |
| 2023 | −$37M | — |
| 2022 | −$29M | — |
| 2021 | −$60M | — |
| 2020 | −$64M | — |
| 2019 | −$57M | — |
| 2018 | −$42M | — |
| 2017 | −$22M | — |
| 2016 | −$6.5M | — |